Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06603441 · ClinicalTrials.gov registry record
Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea
A clinical trial of Obstructive Sleep Apnea of Adult, sponsored by Stanford University.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06603441: Active study of Obstructive Sleep Apnea of Adult, sponsored by Stanford University.
NCT06603441 is a study of Obstructive Sleep Apnea of Adult that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 150 participants, below the 506-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06603441, a study of Obstructive Sleep Apnea of Adult, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)
Primary Outcome
Assessment of the 4% Apnea Hypopnea Index to determine the severity of sleep apnea
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Samsung Galaxy Watch
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-12-17 |
| Est. Completion | 2026-03 |
What the registry record for NCT06603441 still lists
NCT06603441 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 506-participant average among 8 other Obstructive Sleep Apnea of Adult trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Obstructive Sleep Apnea of Adult appearing as the primary indexed condition, and to 1 intervention - of which Samsung Galaxy Watch is the first listed.
NCT06603441 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06603441 about?
NCT06603441 is a clinical study titled "Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea". The study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)
What is the current status of trial NCT06603441?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2024-12-17. Estimated completion is 2026-03.
What conditions does trial NCT06603441 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea of Adult.
What interventions are being tested in trial NCT06603441?
The interventions under investigation include: Samsung Galaxy Watch (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06603441?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06603441 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea of Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06603441's enrollment target sits among peer trials
150 4th of 8 higher than 4 of 8 other Obstructive Sleep Apnea of Adult trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea of Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea
RECRUITING · NA
-
A Cross-sectional Study Examining Adipose Tissue in Obstructive Sleep Apnea
RECRUITING
-
Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
RECRUITING · NA
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Vascular Endothelial Dysfunction in Sleep Apnea
RECRUITING · Phase 1
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI